US Stock MarketDetailed Quotes
CVKD Cadrenal Therapeutics
- 14.990
- +0.980+7.00%
Close Nov 22 16:00 ET
- 15.270
- +0.280+1.87%
Pre 07:00 ET
24.86MMarket Cap-2432P/E (TTM)
15.390High14.040Low113.01KVolume14.050Open14.010Pre Close1.67MTurnover10.33%Turnover RatioLossP/E (Static)1.66MShares32.55052wk High7.29P/B16.40MFloat Cap5.40052wk Low--Dividend TTM1.09MShs Float101.250Historical High--Div YieldTTM9.64%Amplitude5.400Historical Low14.757Avg Price1Lot Size
Cadrenal Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 115.30%2.46M | 140.37%2.47M | -58.20%1.76M | 7.63M | 1.26M | 17.46%1.14M | 112.75%1.03M | 2,363.18%4.2M | 972.79K | 482.35K |
| Selling and administrative expenses | 86.50%1.67M | 54.52%1.21M | 16.72%1.13M | --3.55M | --902.11K | -1.95%898.05K | 180.11%784.62K | 531.94%964.73K | --915.9K | --280.11K |
| -General and administrative expense | 86.50%1.67M | 54.52%1.21M | 16.72%1.13M | --3.55M | --902.11K | -1.95%898.05K | 180.11%784.62K | 531.94%964.73K | --915.9K | --280.11K |
| Research and development costs | 221.64%784.65K | 420.30%1.25M | -80.56%629.03K | --4.08M | --361.13K | 332.62%243.95K | 19.15%240.96K | 18,014.88%3.24M | --56.39K | --202.24K |
| Depreciation amortization depletion | -31.83%407 | -21.27%470 | 214.21%597 | --1.98K | --597 | 17.98%597 | --597 | --190 | --506 | --0 |
| -Depreciation and amortization | -31.83%407 | -21.27%470 | 214.21%597 | --1.98K | --597 | 17.98%597 | --597 | --190 | --506 | --0 |
| Operating profit | -115.30%-2.46M | -140.37%-2.47M | 58.20%-1.76M | -7.63M | -1.26M | -17.46%-1.14M | -112.75%-1.03M | -2,363.18%-4.2M | -972.79K | -482.35K |
| Net non-operating interest income expense | -50.89%52.13K | 217.73%73.64K | 639.89%92.33K | 231.99K | 119.77K | 431.59%106.15K | 256.91%23.18K | -272.65%-17.1K | -32.01K | -14.77K |
| Non-operating interest income | -50.89%52.13K | 217.73%73.64K | --92.33K | --249.09K | --119.77K | 3,538,066.67%106.15K | --23.18K | --0 | --3 | --0 |
| Non-operating interest expense | --0 | --0 | --0 | --17.1K | --0 | --0 | --0 | 272.65%17.1K | --32.01K | --14.77K |
| Other net income (expense) | -956.23K | 0 | -62,073.86%-956.23K | -21.31K | -5.02K | |||||
| Gain on sale of security | ---- | ---- | ---- | ---216.1K | --0 | ---- | ---- | -13,950.39%-216.1K | ---21.31K | ---5.02K |
| Special income (charges) | --0 | --0 | --0 | ---740.14K | --0 | --0 | --0 | ---740.14K | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --740.14K | --0 | ---- | ---- | --740.14K | ---- | ---- |
| Income before tax | -132.31%-2.41M | -138.58%-2.39M | 67.85%-1.66M | -8.36M | -1.14M | -1.01%-1.04M | -99.74%-1M | -2,828.75%-5.17M | -1.03M | -502.14K |
| Income tax | ||||||||||
| Net income | -132.31%-2.41M | -138.58%-2.39M | 67.85%-1.66M | -8.36M | -1.14M | -1.01%-1.04M | -99.74%-1M | -2,828.75%-5.17M | -1.03M | -502.14K |
| Net income continuous Operations | -132.31%-2.41M | -138.58%-2.39M | 67.85%-1.66M | ---8.36M | ---1.14M | -1.01%-1.04M | -99.74%-1M | -2,828.75%-5.17M | ---1.03M | ---502.14K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -132.31%-2.41M | -138.58%-2.39M | 67.85%-1.66M | -8.36M | -1.14M | -1.01%-1.04M | -99.74%-1M | -2,828.75%-5.17M | -1.03M | -502.14K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -132.31%-2.41M | -138.58%-2.39M | 67.85%-1.66M | -8.36M | -1.14M | -1.01%-1.04M | -99.74%-1M | -2,828.75%-5.17M | -1.03M | -502.14K |
| Basic earnings per share | -115.84%-2.18 | -66.67%-2.25 | 79.17%-1.5 | -9.3 | -0.74 | 23.65%-1.01 | -108.53%-1.35 | -3,061.43%-7.2 | -1.3229 | -0.6474 |
| Diluted earnings per share | -115.84%-2.18 | -66.67%-2.25 | 79.17%-1.5 | -9.3 | -0.74 | 23.65%-1.01 | -108.53%-1.35 | -3,061.43%-7.2 | -1.3229 | -0.6474 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data